Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
United Therapeutics Corporation (UTHR) had Receiveable Turnover of 9.09 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.18B |
|
$1.33B |
|
$384.40M |
|
$2.80B |
|
$1.69B |
|
$1.49B |
|
$221.40M |
|
$1.71B |
|
$1.71B |
|
$1.33B |
|
$1.33B |
|
$1.33B |
|
$1.33B |
|
$1.49B |
|
$1.58B |
|
44.30M |
|
47.90M |
|
$30.13 |
|
$27.86 |
|
| Balance Sheet Financials | |
$3.70B |
|
$1.73B |
|
$4.18B |
|
$7.88B |
|
$560.60M |
|
-- |
|
$223.20M |
|
$783.80M |
|
$7.10B |
|
$6.98B |
|
$7.10B |
|
43.64M |
|
| Cash Flow Statement Financials | |
$1.56B |
|
$-551.30M |
|
$-1.15B |
|
$1.70B |
|
$1.56B |
|
$-140.10M |
|
$147.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.92% |
|
46.89% |
|
46.89% |
|
49.58% |
|
53.85% |
|
41.94% |
|
$1.04B |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
2.10 |
|
|
Receiveable Turnover |
9.09 |
40.16 |
|
18.81% |
|
19.12% |
|
16.94% |
|
18.81% |
|
$162.60 |
|
$21.73 |
|
$32.59 |
|